Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
NMTC Stock Chart & Stats
$0.79
-$0.09(-8.05%)
At close: 4:00 PM EST
$0.79
-$0.09(-8.05%)
Day’s Range― - ―
52-Week Range$0.40 - $1.39
Previous CloseN/A
Volume212.44K
Average Volume (3M)532.45K
Market Cap
$41.25M
Enterprise Value$25.22M
Total Cash (Recent Filing)$8.04M
Total Debt (Recent Filing)$295.72K
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Dec 10, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding49,999,520
10 Day Avg. Volume702,340
30 Day Avg. Volume532,447
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue3.81
Enterprise Value/Gross Profit6.72
Enterprise Value/Ebitda-5.59
Forecast
1Y Price Target
$3.00Price Target Upside279.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Awareness And MarketingNMTC continues to build awareness by partnering with patient advocacy groups and investing in social media marketing.
Media ExposureEarned media exposure, including a patient success story featured on Good Morning America, underscores rising interest in the company’s treatment.
Partnership GrowthThe addition of newly trained sales representatives through the company’s partnership with Zimmer Biomet contributed meaningfully to growth.
Bears Say
NeuroOne Medical Technologies News
NMTC FAQ
What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.40 and its highest was $1.39 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
NeuroOne Medical Technologies’s market cap is $41.25M.
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s upcoming earnings report date is Dec 10, 2025 which is in 39 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on Aug 14, 2025. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.05 by $0.02.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Undervalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate is -0.04.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 49,999,520 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.05. Following the earnings report the stock price went down -3.488%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Currently, no hedge funds are holding shares in NMTC
NeuroOne Medical Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (279.75% Upside)
$3.00 (279.75% Upside)
Insider Transactions
Sold Shares
Worth $22.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.29%
12-Months-Change
Fundamentals
Return on Equity
-95.39%
Trailing 12-Months
Asset Growth
120.24%
Trailing 12-Months
Company Description
NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NMTC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was notably positive, highlighting significant revenue growth, successful patient outcomes, new market expansions, and financial stability. While there were concerns about the lack of international sales, the overall progress and achievements outweighed this challenge.View all NMTC earnings summariesNMTC Stock 12 Month Forecast
Average Price Target
$3.00
▲(279.75% Upside)
Technical Analysis
Sensus Healthcare
―
Electrocore
―
Modular Medical
―
Vicarious Surgical
―
Inspira Technologies Oxy BHN
―
Ownership Overview
11.42% Insiders
3.00% Mutual Funds
0.20% Other Institutional Investors
82.80% Public Companies and
Individual Investors